Skip to main content
Top
Published in: Skeletal Radiology 6/2017

01-06-2017 | Scientific Article

Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis

Authors: Matteo Bassetti, Maria Merelli, Fernando Di Gregorio, Paola Della Siega, Maria Screm, Claudio Scarparo, Elda Righi

Published in: Skeletal Radiology | Issue 6/2017

Login to get access

Abstract

Background

Tuberculous spondylodiscitis can be difficult to diagnose because of its nonspecific symptoms and the similarities with non-tubercular forms of spinal infection. Fluorine-18-fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG PET-CT) is increasingly used for the diagnosis and monitoring of tubercular diseases.

Methods

Retrospective, case-control study comparing tuberculous spondylodiscitis with biopsy-confirmed pyogenic spondylodiscitis in the period 2010–2012.

Results

Ten cases of tuberculous spondylodiscitis and 20 controls were included. Compared to pyogenic, tuberculous spondylodiscitis was more frequent in younger patients (P = 0.01) and was more often associated with thoraco-lumbar tract lesions (P = 0.01) and multiple vertebral involvement (P = 0.01). Significantly higher maximum standardized uptake values (SUV) at FDG-PET were displayed by tuberculous spondylodiscitis compared to controls (12.4 vs. 7.3, P = 0.003). SUV levels above 8 showed the highest value of specificity (0.80). Mean SUV reduction of 48% was detected for tuberculous spondylodiscitis at 1-month follow-up.

Conclusions

Higher SUV levels at FDG-PET were detected in tuberculous compared with pyogenic spondylodiscitis. PET-CT use appeared useful in the disease follow-up after treatment initiation.
Literature
1.
go back to reference Trecarichi EM, Di Meco E, Mazzotta V, Fantoni M. Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome. Eur Rev Med Pharmacol Sci. 2012;16 Suppl 2:58–72.PubMed Trecarichi EM, Di Meco E, Mazzotta V, Fantoni M. Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome. Eur Rev Med Pharmacol Sci. 2012;16 Suppl 2:58–72.PubMed
2.
3.
go back to reference Mirsaeidi SM, Tabarsi P, Amiri MV, et al. Clinical and radiological presentation of adult tuberculous spondylitis. Tanaffos. 2003;2(6):59–65. Mirsaeidi SM, Tabarsi P, Amiri MV, et al. Clinical and radiological presentation of adult tuberculous spondylitis. Tanaffos. 2003;2(6):59–65.
4.
go back to reference Dureja S, Sen IB, Acharya S. Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: a prospective clinical observational study. Eur Spine J. 2014;23(11):2449–54.CrossRefPubMed Dureja S, Sen IB, Acharya S. Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: a prospective clinical observational study. Eur Spine J. 2014;23(11):2449–54.CrossRefPubMed
5.
go back to reference Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42:1551–5.PubMed Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42:1551–5.PubMed
6.
go back to reference Yang CM, Hsu CH, Lee CM, Wang FC. Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann Nucl Med. 2003;17:407–10.CrossRefPubMed Yang CM, Hsu CH, Lee CM, Wang FC. Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann Nucl Med. 2003;17:407–10.CrossRefPubMed
7.
go back to reference Heysell SK, Thomas TA, Sifri CD, Rehm PK, Houpt ER. 18-fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series. BMC Pulm Med. 2013;13:14.CrossRefPubMedPubMedCentral Heysell SK, Thomas TA, Sifri CD, Rehm PK, Houpt ER. 18-fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series. BMC Pulm Med. 2013;13:14.CrossRefPubMedPubMedCentral
8.
go back to reference Martinez V, Castilla-Lievre MA, Guillet-Caruba C, et al. (18)F-FDG PET-CT in tuberculosis: an early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis. 2012;16(9):1180–5.CrossRefPubMed Martinez V, Castilla-Lievre MA, Guillet-Caruba C, et al. (18)F-FDG PET-CT in tuberculosis: an early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis. 2012;16(9):1180–5.CrossRefPubMed
9.
go back to reference Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–80.PubMed Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–80.PubMed
10.
go back to reference Amerein PC, Larson SM, Wagner Jr HN. An automated system for measurement of leukocyte metabolism. J Nucl Med. 1975;15:352–5. Amerein PC, Larson SM, Wagner Jr HN. An automated system for measurement of leukocyte metabolism. J Nucl Med. 1975;15:352–5.
11.
go back to reference Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med. 1998;23:739–42.CrossRefPubMed Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med. 1998;23:739–42.CrossRefPubMed
12.
go back to reference Del Giudice G, Bianco A, Cennamo A, Santoro G, Bifulco M, Marzo C, et al. Lung and nodal involvement in nontuberculous mycobacterial disease: PET/CT role. Biomed Res Int. 2015;2015:353202.CrossRefPubMedPubMedCentral Del Giudice G, Bianco A, Cennamo A, Santoro G, Bifulco M, Marzo C, et al. Lung and nodal involvement in nontuberculous mycobacterial disease: PET/CT role. Biomed Res Int. 2015;2015:353202.CrossRefPubMedPubMedCentral
13.
go back to reference Razak A, Rahim NA, Nordin AJ. Dual time point imaging of FDG PET/CT in a tuberculous spondylodiscitis. Biomed Imag Interv. 2010;6(2):e18. Razak A, Rahim NA, Nordin AJ. Dual time point imaging of FDG PET/CT in a tuberculous spondylodiscitis. Biomed Imag Interv. 2010;6(2):e18.
Metadata
Title
Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis
Authors
Matteo Bassetti
Maria Merelli
Fernando Di Gregorio
Paola Della Siega
Maria Screm
Claudio Scarparo
Elda Righi
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 6/2017
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-017-2615-8

Other articles of this Issue 6/2017

Skeletal Radiology 6/2017 Go to the issue